Elimination of pancoast tumor by carboplatin, paclitaxel, and concurrent radiation
- 34 Downloads
Preoperative chemoradiotherapy with carboplatin (AUC 1.5), paclitaxel (40 mg/m2), and concurrent extracorporeal radiation (40 Gy) was used to treat a Pancoast tumor (clinical T3N0M0), without causing adverse events. Then left upper lobectomy was performed along with mediastinal lymph node dissection plus resection of the chest wall and Th, nerve root. Histological examination revealed a pathological complete response. This multimodal regimen was feasible and achieved a good response, so it seems worthwhile to evaluate the clinical effectiveness of the therapy in a cohort study.
Key wordslung cancer surgery chemotherapy radiation therapy preoperative care
Unable to display preview. Download preview PDF.
- 1.Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Johnson D, etal. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001; 121: 472–83.PubMedCrossRefGoogle Scholar
- 2.Pancoast HK. Superior pulmonary sulcus tumors. Tumor characterized by pain, Horner’s syndrome, destruction of bone and atrophy of hand muscles. JAMA 1932; 99: 1391–6.Google Scholar
- 3.Shaw RR, Paulson DL, Kee JL. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154: 29–40.Google Scholar